Granulocyte-monocyte Apheresis in Ulcerative Colitis

Granulocyte-monocyte Apheresis in Steroid-dependent, Azathioprine-intolerant/Resistant Moderate Ulcerative Colitis: a Prospective Multicentre Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03189888

Enrollment

Registered

2017-06-16

Start date

2013-01-31

Completion date

2013-12-31

Last updated

2017-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Brief summary

BACKGROUND: Granulocyte-monocyte apheresis has been proposed for the treatment of ulcerative colitis, although is limited by costs and variability of results.

Interventions

DEVICEapheresis

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* moderate UC with steroid-dependence and azathioprine intolerance or resistance

Design outcomes

Primary

Measure	Time frame
steroid-free clinical remission	3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026